
Opinion|Videos|March 28, 2025
Differentiating Between JAK Inhibitors in Clinical Practice
Panelists discuss how unique characteristics of different JAK inhibitors, including selectivity profiles, administration routes, and clinical efficacy data, inform treatment selection in real-world practice.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
When Hives Do Not Quit: A Practical Update on Chronic Spontaneous Urticaria
2
KT-621 Produces 98% STAT6 Degradation in AD Patients
3
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
4
Site-Specific MED Variability Guides 308-nm Excimer Laser Dosing
5

















